Tildrakizumab (Ilumetri)
Almirall
Description
A subcutaneous injection for plaque psoriasis containing the active ingredient tildrakizumab, which acts on cytokine IL-23.
Indications
Treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy
Price
100mg solution for injection in pre-filled syringe, £CS
More on: Systemic psoriasis treatments